亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Efficacy of statins in treatment and development of non-alcoholic fatty liver disease and steatohepatitis: A systematic review and meta-analysis

医学 脂肪性肝炎 内科学 脂肪肝 荟萃分析 丙氨酸转氨酶 胃肠病学 优势比 天冬氨酸转氨酶 置信区间 转氨酶 疾病 脂肪变性 化学 碱性磷酸酶 生物化学
作者
Kaneez Fatima,Abdul Moeed,Eisha Waqar,Abdul Raafe Atif,Alishba Kamran,Hura Rizvi,Noor Fatima Suri,Hoorain Haider,Syed Hasan Shuja,Mariam Khalid,Abdul Mannan Khan Minhas
出处
期刊:Clinics and Research in Hepatology and Gastroenterology [Elsevier]
卷期号:46 (4): 101816-101816 被引量:37
标识
DOI:10.1016/j.clinre.2021.101816
摘要

Non-Alcoholic Fatty Liver Disease (NAFLD) is one of the most common causes of chronic liver disease worldwide. There is no universally accepted effective treatment for NAFLD. Although various studies propose statins effective in lowering liver enzymes and in improving liver histology, their potency in the treatment and development of NAFLD remains unknown.We conducted this meta-analysis to evaluate the efficacy of statins in the treatment and the development of NAFLD.Electronic databases (MEDLINE and Cochrane CENTRAL) were searched from their inception until May 2021 for observational studies and randomized controlled trials (RCTs) that assessed the efficacy of statins for the treatment of NAFLD and its development. Studies were included irrespective of the dosage or duration, and their risk of bias was assessed. The outcomes of interest for our study were the effect of statins on liver histology (steatosis, fibrosis and necroinflammation, NAFLD activity score [NAS]) and liver enzymes (Alanine transaminase [ALT], Aspartate transaminase [AST], and Gamma-glutamyl transferase [GGT] levels). To pool continuous outcomes, a random-effects model was used to derive weighted mean difference (WMD) or standardized mean difference (SMD) and their corresponding 95% confidence intervals (CIs). Generic inverse variance was then used for different measurement units reported by the studies. For studies investigating the effects of statins on the development of NAFLD, generic inverse variance along with random effects model was used to derive odds ratio (ORs) and its corresponding 95% confidence interval (CI).A total of 14 studies including 1,247,503 participants were short-listed for our analysis. All the studies included in our analysis had a low to moderate risk of bias. The results of our analysis suggest that statins may significantly reduce the risk of developing NAFLD (OR:0.69, 95% CI [0.57,0.84]; p = 0.0002; I² =36%). Statin use significantly reduced ALT levels (WMD: -27.28, 95% CI [-43.06, -11.51]; p = 0.0007; I² =90%), AST levels (WMD: -10.99, 95% CI [-18.17, -3.81]; p = 0.003; I² =79%) and GGT levels (WMD: -23.40, 95% CI [-31.82, -14.98]; p < 0.00001; I² = 21%) in patients presenting with NAFLD at baseline. In liver histology outcomes, steatosis grade (SMD: -2.59, 95% CI [-4.61, -0.56]; p = 0.01; I² = 95%), NAS (WMD: -1.03, 95% CI [-1.33, -0.74]; p < 0.00001; I² = 33%), necro-inflammatory stage (WMD: -0.19, 95% CI [-0.26, -0.13]; p < 0.00001; I² = 0%) and significant fibrosis (OR:0.20, 95% CI [0.04, 0.95]; p = 0.04; I² = 97%) underwent notable reduction. However, fibrosis stage outcome (WMD: 0.07, 95% CI [-0.05, 0.20]; p = 0.27; I² = 0%) was non-significant.There was a significant decrease in transaminase and transferase levels. Marked improvement in liver histology of NAFLD patients was observed. Statin use also remarkably reduced the risk of developing NAFLD. Future large-scale trials can further aid in identifying the positive impact of statins in treatment for NAFLD and those at risk of developing it.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
4秒前
星辰大海应助李小猫采纳,获得10
21秒前
24秒前
28秒前
李小猫完成签到,获得积分10
29秒前
30秒前
吕lvlvlvlvlv发布了新的文献求助10
30秒前
31秒前
李小猫发布了新的文献求助10
33秒前
JAsoli发布了新的文献求助10
34秒前
科研通AI2S应助科研通管家采纳,获得10
35秒前
36秒前
语嘘嘘发布了新的文献求助10
39秒前
Anthology发布了新的文献求助10
40秒前
炙热香关注了科研通微信公众号
41秒前
彭于晏应助zhuhan采纳,获得10
46秒前
54秒前
zhuhan发布了新的文献求助10
59秒前
sky完成签到 ,获得积分10
1分钟前
1分钟前
炙热香发布了新的文献求助10
1分钟前
1分钟前
1分钟前
bryceeluo发布了新的文献求助10
1分钟前
安详向薇完成签到,获得积分10
1分钟前
璨澄完成签到 ,获得积分10
1分钟前
1分钟前
科研通AI2S应助青葱年华rr采纳,获得10
1分钟前
1分钟前
忧郁的寻冬完成签到,获得积分10
1分钟前
1分钟前
清爽老九应助alpv采纳,获得10
1分钟前
shy发布了新的文献求助10
1分钟前
1分钟前
Xm发布了新的文献求助10
1分钟前
开心岩发布了新的文献求助10
1分钟前
开心岩完成签到,获得积分10
1分钟前
科研通AI2S应助shy采纳,获得10
1分钟前
拉长的元芹应助caster1采纳,获得10
1分钟前
奈思完成签到 ,获得积分10
2分钟前
高分求助中
Licensing Deals in Pharmaceuticals 2019-2024 3000
Cognitive Paradigms in Knowledge Organisation 2000
Introduction to Spectroscopic Ellipsometry of Thin Film Materials Instrumentation, Data Analysis, and Applications 1800
Natural History of Mantodea 螳螂的自然史 1000
A Photographic Guide to Mantis of China 常见螳螂野外识别手册 800
How Maoism Was Made: Reconstructing China, 1949-1965 800
Barge Mooring (Oilfield Seamanship Series Volume 6) 600
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3314374
求助须知:如何正确求助?哪些是违规求助? 2946617
关于积分的说明 8531095
捐赠科研通 2622350
什么是DOI,文献DOI怎么找? 1434478
科研通“疑难数据库(出版商)”最低求助积分说明 665329
邀请新用户注册赠送积分活动 650855